Javascript must be enabled to continue!
NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting
View through CrossRef
Abstract
Endothelial cells express neuropilin 1 (NRP1), endoglin (ENG) and vascular endothelial growth factor receptor 2 (VEGFR2), which regulate VEGF-A-mediated vascular development and angiogenesis. However, the link between complex formation among these receptors with VEGF-A-induced signaling and biology was unclear. Here, we quantified surface receptor interactions by IgG-mediated immobilization of one receptor, and fluorescence recovery after photobleaching (FRAP) measurements of the mobility of another coexpressed receptor. We observed stable ENG/NRP1, ENG/VEGFR2, and NRP1/VEGFR2 complexes, which were enhanced by VEGF-A. ENG augmented NRP1/VEGFR2 interactions, suggesting formation of tripartite complexes bridged by ENG. Effects on signaling were measured in murine embryonic endothelial cells expressing (MEEC+/+) or lacking (MEEC-/-) ENG, along with NRP1 overexpression or knockdown. Optimal VEGF-A-mediated phosphorylation of VEGFR2 and Erk1/2 required ENG and NRP1. ENG or NRP1 increased VEGF-A-induced sprouting, becoming optimal in cells expressing all three receptors, and both processes were inhibited by a MEK1/2 inhibitor. We propose a model where the maximal potency of VEGF-A involves a tripartite complex where ENG bridges VEGFR2 and NRP1, providing an attractive therapeutic target for modulation of VEGF-A signaling and biological responses.
Springer Science and Business Media LLC
Title: NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting
Description:
Abstract
Endothelial cells express neuropilin 1 (NRP1), endoglin (ENG) and vascular endothelial growth factor receptor 2 (VEGFR2), which regulate VEGF-A-mediated vascular development and angiogenesis.
However, the link between complex formation among these receptors with VEGF-A-induced signaling and biology was unclear.
Here, we quantified surface receptor interactions by IgG-mediated immobilization of one receptor, and fluorescence recovery after photobleaching (FRAP) measurements of the mobility of another coexpressed receptor.
We observed stable ENG/NRP1, ENG/VEGFR2, and NRP1/VEGFR2 complexes, which were enhanced by VEGF-A.
ENG augmented NRP1/VEGFR2 interactions, suggesting formation of tripartite complexes bridged by ENG.
Effects on signaling were measured in murine embryonic endothelial cells expressing (MEEC+/+) or lacking (MEEC-/-) ENG, along with NRP1 overexpression or knockdown.
Optimal VEGF-A-mediated phosphorylation of VEGFR2 and Erk1/2 required ENG and NRP1.
ENG or NRP1 increased VEGF-A-induced sprouting, becoming optimal in cells expressing all three receptors, and both processes were inhibited by a MEK1/2 inhibitor.
We propose a model where the maximal potency of VEGF-A involves a tripartite complex where ENG bridges VEGFR2 and NRP1, providing an attractive therapeutic target for modulation of VEGF-A signaling and biological responses.
Related Results
Elevated plasma endoglin (CD105) predicts decreased response and survival in metastatic breast cancer patients
Elevated plasma endoglin (CD105) predicts decreased response and survival in metastatic breast cancer patients
10091 Background: Endoglin (CD105) is a proliferation-associated surface protein expressed by human vascular endothelial cells. It is a co-receptor for transforming growth factor ...
Abstract 1811: A PEAK1/GATA2 signaling axis controls VEGFR2 expression to mediate angiogenesis
Abstract 1811: A PEAK1/GATA2 signaling axis controls VEGFR2 expression to mediate angiogenesis
Abstract
Formation of new blood vessels (angiogenesis) is crucial for proper development, but can also contribute to many diseases including cancer. Vascular endothe...
Genetic mosaics reveal mechanisms of resistance to VEGF signaling loss during angiogenesis
Genetic mosaics reveal mechanisms of resistance to VEGF signaling loss during angiogenesis
Abstract
The VEGF ligand and its main receptor VEGFR2 are considered to be essential for endothelial differentiation, proliferation, sprouting and survival. Blood v...
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
C. Christov, H. Adle‐Biassette, C. Le Guerinel, S. Natchev and R. K. Gherardi (1998) Neuropathology and Applied Neurobiology24, 29–35Immunohistochemical detection of vascular endot...
Deciphering Molecular Control of VEGFR2 Regulation in Hematopoietic Progenitors: GATA1-Mediated Repression of VEGFR2 Promotes Optimum Erythropoiesis
Deciphering Molecular Control of VEGFR2 Regulation in Hematopoietic Progenitors: GATA1-Mediated Repression of VEGFR2 Promotes Optimum Erythropoiesis
Abstract
VEGFR2 (also known as Flk1) is expressed in hemetopoietic precursors and is essential for both hematopoietic and vascular development. Interestingly, develo...
Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma*
Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma*
Background & Aims: Vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 and VEGF-R2) are the most important angiogenesis stimulating factors in pancreatic cance...
VEGF Receptor Signal Transduction
VEGF Receptor Signal Transduction
The family of vascular endothelial growth factors (VEGFs) currently includes VEGF-A, -B, -C, -D, -E, and placenta growth factor (PlGF). Several of these factors, notably VEGF-A, ex...
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Tumor cells express vascular endothelial growth factor (VEGF) that can activate VEGF receptors (VEGFRs) on or within tumor cells to promote growth in an angiogenesis-independent fa...

